fulvestrant
Showing 1 - 25 of 254
Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)
Not yet recruiting
- Breast Cancer
- +5 more
- PF-07224826
- Fulvestrant
- (no location specified)
Jun 7, 2023
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)
Recruiting
- Metastatic Breast Cancer
- +2 more
- Samuraciclib
- Fulvestrant
-
Ocala, FloridaOcala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023
Advanced or Metastatic Breast Cancer Trial (PF-07220060, Fulvestrant, Everolimus)
Not yet recruiting
- Advanced or Metastatic Breast Cancer
- PF-07220060
- +3 more
- (no location specified)
Oct 24, 2023
Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,
Recruiting
- Premenopausal Breast Cancer
- +2 more
- Goserelin
- +3 more
-
Taipei City, TaiwanDepartment of Oncology, National Taiwan University Hospital
Feb 7, 2023
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)
Not yet recruiting
- Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
- Giredestrant
- +6 more
- (no location specified)
Sep 26, 2023
Metastatic Breast Cancer Trial in United States (Lenvatinib, Pembrolizuma, Fulvestrant)
Not yet recruiting
- Metastatic Breast Cancer
- Lenvatinib
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Oct 31, 2023
Breast Cancer Trial in Tianjin (Dalpiciclib, Pyrotinib, Fulvestrant)
Not yet recruiting
- Breast Cancer
- Dalpiciclib
- +2 more
-
Tianjin, ChinaTianjin Cancer Hospital
Mar 28, 2023
Malignant Tumors of Female Genital Organs Trial in Houston (Fulvestrant, Abemaciclib)
Active, not recruiting
- Malignant Neoplasms of Female Genital Organs
- Fulvestrant
- Abemaciclib
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 5, 2022
Breast Cancer Trial in Shanghai (Dalpiciclib, Fulvestrant, Pertuzumab)
Active, not recruiting
- Breast Cancer
- Dalpiciclib
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 10, 2022
Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)
Not yet recruiting
- Advanced Breast Cancer
- Olaparib
- Fulvestrant
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 12, 2022
Breast Cancer Trial in Shanghai (Chidamide, Abemaciclib, Fulvestrant)
Recruiting
- Breast Cancer
- Chidamide
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 31, 2022
Advanced Breast Cancer Trial in Thalassery (Alpelisib, Fulvestrant)
Recruiting
- Advanced Breast Cancer
- Alpelisib
- Fulvestrant
-
Thalassery, Kerala, IndiaNovartis Investigative Site
Nov 21, 2022
ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer, a Germline or Somatic BRCA Mutation, or a
Recruiting
- ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer
- a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
- Durvalumab
- +2 more
-
Montpellier, France
- +1 more
Nov 16, 2022
Endometrial Cancer, Ovarian Cancer Trial in Houston (Copanlisib, fulvestrant)
Recruiting
- Endometrial Cancer
- Ovarian Cancer
- Copanlisib
- fulvestrant
-
Houston, TexasM D Anderson Cancer Center
Sep 27, 2022
Adenocarcinoma of Endometrium Trial in United States (Fulvestrant, Abemaciclib)
Recruiting
- Adenocarcinoma of Endometrium
- Fulvestrant
- Abemaciclib
-
Basking Ridge, New Jersey
- +6 more
Oct 12, 2022
ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Cancer Trial in Madison, Milwaukee (Onapristone, Fulvestrant)
Recruiting
- ER-positive Breast Cancer
- +2 more
- Onapristone
- Fulvestrant
-
Madison, Wisconsin
- +1 more
Jul 7, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Binimetinib
- +5 more
- (no location specified)
Nov 8, 2022
Advanced Breast Cancer Trial in Changsha (BEBT-209 capsules, Letrozole tablets, Fulvestrant)
Active, not recruiting
- Advanced Breast Cancer
- BEBT-209 capsules
- +2 more
-
Changsha, Hunan, China
- +1 more
Sep 14, 2023
Advanced Solid Tumor, Breast Cancer Trial in Columbus, San Antonio, West Valley City (CFI-402257, Fulvestrant)
Recruiting
- Advanced Solid Tumor
- Breast Cancer
- CFI-402257
- Fulvestrant
-
Columbus, Ohio
- +2 more
Jul 26, 2022